Byongen Therapeutics
PrivateLast Round
VC Round
Sep 18, 2023
Total Funding Raised
$4.7M
Company Overview
Byongen Therapeutics operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a VC Round in September 2023.
Byongen Therapeutics is a biotechnology company that specializes in original gene delivery innovations, specifically focusing on AAV capsid engineering to develop safer and more efficient gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Byongen Therapeutics Comparables
Compare Byongen Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dyno Therapeutics | 86% | |
| Lir Therapeutics | 84% | |
| rAAVen Therapeutics | 84% |
For institutional investors. Book with your work email.
Byongen Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 18, 2023 | ||||
| Pre Seed | Mar 4, 2022 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2023
Raised $14M in a venture round.
- Mar 4, 2022
$4.7M raised in Pre Seed round.
For institutional investors. Book with your work email.
Byongen Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Byongen Therapeutics's valuation, stock price, and market status.
Is Byongen Therapeutics a public or private company?
Byongen Therapeutics is a private company.
What is the current stock price of Byongen Therapeutics?
Byongen Therapeutics is a private company, so its shares have no public market price. Caplight tracks Byongen Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Byongen Therapeutics worth (valuation)?
Valuation information for Byongen Therapeutics is not publicly available.
Can I buy Byongen Therapeutics stock?
Byongen Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Byongen Therapeutics's last funding round?
Byongen Therapeutics's most recent funding round was VC Round on September 18, 2023.
Who are the main investors in Byongen Therapeutics?
Investor information for Byongen Therapeutics is not publicly disclosed.
Will Byongen Therapeutics IPO soon?
No public IPO plans have been announced for Byongen Therapeutics.
How can I track Byongen Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Byongen Therapeutics's shares on secondary markets.